New Breakthrough Alzheimer's Drug Approved!

In this video, Dr. Sanjeev and Carmelia Ray discuss the latest development in the fight against Alzheimer's disease. Sanjeev, currently attending an anti-aging conference in Orlando, Florida, shares insights on the theme of inflammation as a root cause of aging. The highlight of the video is their conversation about Leqembi, a medication recently submitted to Health Canada for approval. They elaborate on the drug's functioning, its potential benefits and drawbacks, and how it could be a game changer in slowing the progression of Alzheimer's disease. If approved, Leqembi will be the first Alzheimer's treatment in Canada. The hosts also emphasize the importance of early detection for effective treatment and the potential of PET scans in diagnosing amyloid deposits in the brain. Tune in for cutting-edge updates on Alzheimer's research, the importance of prevention, and new treatments.
********************
Visit our website: https://peakhuman.ca/?v=3e8d115eb4b3
Shop here: https://peakhuman.ca/shop/
SUBSCRIBE TODAY: https://bit.ly/PeakHumanLabs
******************
TIMESTAMP
0:00 - Introduction
0:48 - Sanjeev's Perspective on Alzheimer's Treatment
1:26 - About Amyloid Buildup and Alzheimer's Medication
2:14 - Functionality of the New Medication
2:57 - Study on Alzheimer's Medication
3:18 - Improvements from the Treatment
3:37 - Progression of Alzheimer's
4:02 - Risks of the New Medication
4:26 - Cost of the Treatment
5:02 - Alzheimer's Society of Ontario's View on the Treatment
5:38 - Hope for Patients
6:03 - Importance of Diagnosis
6:36 - Different Types of Alzheimer's Medications
7:00 - Effectiveness of Early Treatment
7:36 - Importance of Testing
8:06 - Latest Updates in Alzheimer's Research
8:34 - Sanjeev's Experience and Learning
9:02 - Detection of Amyloid Deposits
9:33 - What is a PET Scan?
10:02 - Access to PET Scan in Canada

#AlzheimersBreakthrough #NewAlzheimersDrug #AlzheimersTreatment